2-[3-(2-Ethoxy-3-iodo-5-methoxy-benzylamino)-propylamino]-1H-quinolin-4-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-[3-(2-Ethoxy-3-iodo-5-methoxy-benzylamino)-propylamino]-1H-quinolin-4-one
• 英文别名: 2-[3-[(2-ethoxy-3-iodo-5-methoxyphenyl)methylamino]propylamino]-1H-quinolin-4-one
• 化学式: C₂₂H₂₆IN₃O₃
• 分子量: 507.371
• InChiKey: AFPDWMDEFWFAIL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  29
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  71.6
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  N1-(4-(4-methoxybenzyloxy)quinolin-2-yl)propane-1,3-diamine 、 2-Ethoxy-3-iodo-5-methoxy-benzaldehyde 在 resin-bound cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 生成 2-[3-(2-Ethoxy-3-iodo-5-methoxy-benzylamino)-propylamino]-1H-quinolin-4-one
  参考文献：
  名称：

  Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity

  摘要：

  Optimisation of the left-hand-side aryl moiety of a file compound screening hit against Staphylococcus aureus methionyl tRNA synthetase led to the identification of a series of potent nanomolar inhibitors. The best compounds showed excellent antibacterial activity against staphylococcal and enterococcal pathogens. including strains resistant to clinical antibiotics. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)01027-2

文献信息

• Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity
  作者：Richard L Jarvest、John M Berge、Murray J Brown、Pamela Brown、John S Elder、Andrew K Forrest、C.S.V Houge-Frydrych、Peter J O'Hanlon、David J McNair、Stephen Rittenhouse、Robert J Sheppard

  DOI：10.1016/s0960-894x(02)01027-2

  日期：2003.2

  Optimisation of the left-hand-side aryl moiety of a file compound screening hit against Staphylococcus aureus methionyl tRNA synthetase led to the identification of a series of potent nanomolar inhibitors. The best compounds showed excellent antibacterial activity against staphylococcal and enterococcal pathogens. including strains resistant to clinical antibiotics. (C) 2003 Elsevier Science Ltd. All rights reserved.